We are live on ! Find out more
GGI

Godsey & Gibb Inc Portfolio holdings

AUM $1.22B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+27.93%
3 Year Est. Return
+78.89%
5 Year Est. Return
+79.48%
10 Year Est. Return
+248.77%
AUM
$1B
AUM Growth
-$43.8M
Cap. Flow
-$17M
Cap. Flow %
-1.7%
Top 10 Hldgs %
29.71%
Holding
444
New
13
Increased
38
Reduced
99
Closed
76

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$19.3M
2
AAPL icon
Apple
AAPL
+$1.02M
3
MRK icon
Merck
MRK
+$987K
4
SWK icon
Stanley Black & Decker
SWK
+$795K
5
AMGN icon
Amgen
AMGN
+$606K

Top Sells

Rank Stock Value
1
BCE icon
BCE
BCE
+$15.9M
2
ADM icon
Archer Daniels Midland
ADM
+$15.8M
3
ORCL icon
Oracle
ORCL
+$1.39M
4
IBM icon
IBM
IBM
+$958K
5
AVGO icon
Broadcom
AVGO
+$942K

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Financials 16.18%
3 Industrials 12.57%
4 Healthcare 11.75%
5 Utilities 10.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KD icon
301
Kyndryl
KD
$3.05B
$5.43K ﹤0.01%
157
– –
CDNS icon
302
Cadence Design Systems
CDNS
$93.4B
$5.41K ﹤0.01%
18
– –
CEG icon
303
Constellation Energy
CEG
$95.6B
$5.37K ﹤0.01%
24
– –
GM icon
304
General Motors
GM
$76.8B
$5.33K ﹤0.01%
100
– –
BXMT icon
305
Blackstone Mortgage Trust
BXMT
$2.38B
$5.22K ﹤0.01%
300
– –
KHC icon
306
Kraft Heinz
KHC
$30B
$5.22K ﹤0.01%
170
– –
STM icon
307
STMicroelectronics
STM
$50B
$4.99K ﹤0.01%
200
-200
-50% -$5.31K
AGNC icon
308
AGNC Investment
AGNC
$12.9B
$4.97K ﹤0.01%
540
– –
DEO icon
309
Diageo
DEO
$53.6B
$4.96K ﹤0.01%
39
-101
-72% -$12.8K
DD icon
310
DuPont de Nemours
DD
$19.2B
$4.96K ﹤0.01%
52
– –
AVB icon
311
AvalonBay Communities
AVB
$26.8B
$4.62K ﹤0.01%
21
– –
ED icon
312
Consolidated Edison
ED
$39.9B
$4.46K ﹤0.01%
50
– –
CIVI
313
DELISTED
Civitas Resources
CIVI
$4.36K ﹤0.01%
95
– –
ALB icon
314
Albemarle
ALB
$15.5B
$4.3K ﹤0.01%
50
– –
PJT icon
315
PJT Partners
PJT
$4.38B
$3.95K ﹤0.01%
25
– –
GEHC icon
316
GE HealthCare
GEHC
$32.4B
$3.91K ﹤0.01%
50
– –
PLTR icon
317
Palantir
PLTR
$413B
$3.78K ﹤0.01%
50
– –
QYLD icon
318
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.26B
$3.64K ﹤0.01%
200
– –
SAND
319
DELISTED
Sandstorm Gold
SAND
$3.63K ﹤0.01%
650
– –
SUPN icon
320
Supernus Pharmaceuticals
SUPN
$2.77B
$3.62K ﹤0.01%
100
– –
BTG icon
321
B2Gold
BTG
$6.64B
$3.4K ﹤0.01%
1,395
– –
EMBC icon
322
Embecta
EMBC
$262M
$3.26K ﹤0.01%
158
– –
BCE icon
323
BCE
BCE
$21.2B
$3.25K ﹤0.01%
140
-553,889
-100% -$15.9M
AZN icon
324
AstraZeneca
AZN
$250B
$3.21K ﹤0.01%
25
– –
WBA
325
DELISTED
Walgreens Boots Alliance
WBA
$3.01K ﹤0.01%
323
– –
11 12
13
14 15

Similar funds

AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
DGM
Delta Global Management New York $1.22B AUM 34.86% 1-Year Est. Return
SC
Strategy Capital Los Altos, California $1.22B AUM 27.02% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return

Godsey & Gibb Inc's Q4 2024 Portfolio in Review

As of Q4 2024, Godsey & Gibb Inc held 444 positions worth $1B, down 4.2% from $1.05B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Godsey & Gibb Inc's Q4 2024 filing shows 13 new, 38 increased, 99 reduced and 76 closed positions. Its largest new stake was State Street: 203,480 shares worth $20M. The largest sale was BCE, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

  • Godsey & Gibb Inc's largest Q4 2024 buy was State Street: 203,480 shares worth $20M.
  • Godsey & Gibb Inc added most to Apple in Q4 2024, an estimated $1.02M increase.
  • Godsey & Gibb Inc's biggest Q4 2024 reduction was BCE, cutting an estimated $15.9M.
  • Godsey & Gibb Inc fully exited Regeneron Pharmaceuticals in Q4 2024, selling an estimated $137K.
  • Godsey & Gibb Inc's ten largest holdings make up 30% of its $1B portfolio in Q4 2024.
  • Godsey & Gibb Inc opened 13 new positions and closed 76 in Q4 2024.
  • Godsey & Gibb Inc's portfolio value fell 4.2% quarter-over-quarter to $1B.

Based on Godsey & Gibb Inc's 13F filing for Q4 2024, filed 14 Jan 2025.